Literature DB >> 15221941

Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.

Keisuke Kato1, Yukio Nakatani, Hiroshi Kanno, Yoshiyuki Inayama, Rieko Ijiri, Noriyuki Nagahara, Tetsumi Miyake, Mio Tanaka, Yumi Ito, Noriko Aida, Katsuhiko Tachibana, Ken-ichi Sekido, Yukichi Tanaka.   

Abstract

This study concerns the significance of nuclear/cytoplasmic expression of beta-catenin and mutation of the beta-catenin gene in craniopharyngiomas. Fourteen adamantinomatous type and one squamous papillary type craniopharyngiomas were studied. Histologically, 13 of 14 adamantinomatous type craniopharyngiomas showed typical features, ie mixtures of 'palisading cells', 'stellate cells', and 'ghost cells'. In addition, 'whorl-like arrays' of epithelial cells were frequently observed in the areas of stellate cells. On immunohistochemistry, all typical adamantinomatous type craniopharyngiomas showed nuclear/cytoplasmic expression of beta-catenin predominantly in cohesive cells within the whorl-like arrays and in cells transitional towards ghost cells, where immunoreactivity for Ki-67 was almost absent. The cohesive cells in the whorl-like arrays also demonstrated loss of cytokeratin isoform expression. Using direct sequencing of amplified nucleic acids, nine of the 13 typical adamantinomatous type craniopharyngiomas with nuclear beta-catenin accumulation showed heterozygous one-base substitution mutation of the beta-catenin gene. The other unusual adamantinomatous type and squamous papillary type craniopharyngiomas showed no obvious nuclear/cytoplasmic beta-catenin immunoreactivity and no mutation of the beta-catenin gene, suggesting molecular heterogeneity. These findings suggest that the pathogenesis of typical adamantinomatous type craniopharyngioma is associated with abnormalities of Wnt signalling that act as a morphogenetic signal towards whorl-like arrays and ghost cells rather than as simple proliferation stimuli. Copyright 2004 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221941     DOI: 10.1002/path.1562

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  38 in total

Review 1.  Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up.

Authors:  Hermann L Müller
Journal:  Nat Rev Endocrinol       Date:  2010-09-28       Impact factor: 43.330

Review 2.  Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke's cleft cyst with corticotroph adenoma.

Authors:  N Karavitaki; B W Scheithauer; J Watt; O Ansorge; M Moschopoulos; A V Llaguno; J A H Wass
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 3.  Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview.

Authors:  Ruth Prieto; José M Pascual
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

Review 4.  Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon.

Authors:  Christopher Salvatore Graffeo; Avital Perry; Michael J Link; David J Daniels
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-19

5.  Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.

Authors:  Prit Benny Malgulwar; Aruna Nambirajan; Pankaj Pathak; Mohammed Faruq; Vaishali Suri; Chitra Sarkar; Amandeep Jagdevan; Bhawani Shankar Sharma; Mehar Chand Sharma
Journal:  J Neurooncol       Date:  2017-05-12       Impact factor: 4.130

6.  Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?

Authors:  Annett Hölsken; Christina Stache; Sven Martin Schlaffer; Jörg Flitsch; Rudolf Fahlbusch; Michael Buchfelder; Rolf Buslei
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

7.  CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas.

Authors:  Marina Lanciotti Campanini; Leandro Machado Colli; Beatriz Maria Carvalho Paixao; Tatiana Pereira Freitas Cabral; Fernando Colbari Amaral; Helio Rubens Machado; Luciano Serafin Neder; Fabiano Saggioro; Ayrton Custodio Moreira; Sonir Roberto Rauber Antonini; Margaret de Castro
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

Review 8.  Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review.

Authors:  Josephine R Coury; Brittany N Davis; Christoforos P Koumas; Giovanna S Manzano; Amir R Dehdashti
Journal:  Neurosurg Rev       Date:  2018-04-17       Impact factor: 3.042

9.  A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas.

Authors:  Stefanie Burghaus; Annett Hölsken; Michael Buchfelder; Rudolf Fahlbusch; Beat M Riederer; Volkmar Hans; Ingmar Blümcke; Rolf Buslei
Journal:  Virchows Arch       Date:  2010-03       Impact factor: 4.064

10.  Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans.

Authors:  Carles Gaston-Massuet; Cynthia Lilian Andoniadou; Massimo Signore; Sujatha A Jayakody; Nicoletta Charolidi; Roger Kyeyune; Bertrand Vernay; Thomas S Jacques; Makoto Mark Taketo; Paul Le Tissier; Mehul T Dattani; Juan Pedro Martinez-Barbera
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.